Expert Perspectives on the Optimal Management of Sickle Cell Disease

Experts discuss challenges in sickle cell disease along with the available standard of care and newer FDA-approved agents used in the management of the disease.

EP. 1: Understanding Sickle Cell Disease

March 31st 2021

Wally Smith, MD, and Abdullah Kutlar, MD provide an overview of sickle cell disease and its pathophysiology.

EP. 2: Prevalence and Burden of SCD

March 31st 2021

Experts discuss the prevalence and burden of sickle cell disease.

EP. 3: Acute and Chronic Complications in SCD 

April 7th 2021

Key opinion leaders give insight on the presentation of sickle cell disease, also highlighting acute vs chronic complications of the disease.

EP. 4: Anemia-Related SCD Manifestation: Monitoring and Screening

April 7th 2021

Abdullah Kutlar, MD, reviews the guideline recommendations for screening and monitoring of anemia-related sickle cell disease manifestations.

EP. 5: Impact of SCD on Quality of Life

April 14th 2021

Clinicians dive into the impact of sickle cell on quality of life and symptom management

EP. 6: Hydroxyurea in Sickle Cell Disease

April 14th 2021

Patrick McGann, MD, MS, reviews the role of hydroxyurea in sickle cell disease, touching on the mechanism of action and expected outcomes.

EP. 7: Role of L-Glutamine in SCD

April 21st 2021

Wally Smith, MD, discusses L-glutamine in the treatment of SCD.

EP. 8: Screening and Monitoring for Red Blood Cell Transfusion

April 21st 2021

Insight on the screening and monitoring for red blood cell transfusion for the management of sickle cell disease.

EP. 9: Considerations for HSCT in Sickle Cell Disease

April 28th 2021

Experts discuss the considerations, as well as a specific case in patients receiving hemopoietic stem cell transplant (HSCT).

EP. 10: Benefits and Risks of HSCT in SCD

April 28th 2021

Abdullah Kutlar, MD, reviews the benefits and risks of treating patients with hemopoietic stem cell transplant.